State Street Corp increased its holdings in OrthoPediatrics Corp. (NASDAQ:KIDS – Free Report) by 1.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 417,898 shares of the company’s stock after acquiring an additional 4,236 shares during the period. State Street Corp owned about 1.73% of OrthoPediatrics worth $11,329,000 at the end of the most recent reporting period.
Other institutional investors have also recently bought and sold shares of the company. Commonwealth Equity Services LLC lifted its position in shares of OrthoPediatrics by 0.6% in the second quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock worth $2,098,000 after purchasing an additional 420 shares in the last quarter. Triodos Investment Management BV increased its stake in OrthoPediatrics by 1.2% in the 2nd quarter. Triodos Investment Management BV now owns 41,500 shares of the company’s stock valued at $1,194,000 after buying an additional 500 shares during the period. Trust Point Inc. increased its stake in OrthoPediatrics by 10.0% in the 3rd quarter. Trust Point Inc. now owns 8,532 shares of the company’s stock valued at $231,000 after buying an additional 773 shares during the period. Quarry LP purchased a new stake in OrthoPediatrics in the 3rd quarter worth approximately $25,000. Finally, International Assets Investment Management LLC boosted its stake in shares of OrthoPediatrics by 2,610.8% during the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after buying an additional 966 shares during the period. 69.05% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
KIDS has been the subject of several recent research reports. Truist Financial cut their price objective on OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price target on shares of OrthoPediatrics in a research note on Friday, November 8th. Finally, JMP Securities reiterated a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a report on Friday, September 13th.
OrthoPediatrics Trading Down 0.2 %
Shares of NASDAQ:KIDS opened at $22.58 on Thursday. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The stock has a market capitalization of $546.80 million, a PE ratio of -18.36 and a beta of 1.14. OrthoPediatrics Corp. has a 1 year low of $21.02 and a 1 year high of $36.23. The firm has a fifty day moving average price of $25.10 and a 200 day moving average price of $27.99.
OrthoPediatrics Profile
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.
Read More
- Five stocks we like better than OrthoPediatrics
- What Are Growth Stocks and Investing in Them
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is a Death Cross in Stocks?
- 2 Drone Stocks Surging from Increased Media Attention
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for OrthoPediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics and related companies with MarketBeat.com's FREE daily email newsletter.